Named as a key player in 264 of our reports, across 33 regions and countries.
| Market | Category | World size | Growth |
|---|---|---|---|
| Cystic Fibrosis Therapeutics | Pharmaceuticals | In full report | In full report |
| Gene Editing | Pharmaceuticals | In full report | In full report |
| Neuropathic Pain Treatment | Pharmaceuticals | In full report | In full report |
| Non-Opioid Pain Drugs | Pharmaceuticals | In full report | In full report |
| Orphan Drugs | Pharmaceuticals | In full report | In full report |
| Pain Management Drugs | Pharmaceuticals | In full report | In full report |
| Sickle Cell Disease Therapeutics | Pharmaceuticals | In full report | In full report |
| Stem Cell Therapy | Pharmaceuticals | In full report | In full report |
Named as key players in the same markets as Vertex Pharmaceuticals (number of shared markets).
Pfizer Inc.4 shared markets
Grunenthal2 shared markets
Novartis AG2 shared markets
Takeda Pharmaceutical Company Ltd2 shared markets
AbbVie Inc.1 shared market
Alexion (AstraZeneca)1 shared market
Beam Therapeutics1 shared market
bluebird bio1 shared market